Directors of Cavendish (LSE:CAV), the UK Investment bank that says it advises more AIM-quoted companies than any rival, have bought shares after a tougher first half. A regulatory filing on 12 November 2026 showed that chair Lisa Gordon, chief executive Julian Morse and chief financial officer Ben Procter all bought stock on 11 November, at prices between about 5.95p and 6.30p, the day the group reported interim results and a board change.

What the company does

Cavendish (LSE:CAV) advises public and private companies. Its Investment Banking arm earns corporate retainers and fees from Equity capital markets, M&A, Debt and private placings, while its equities Business generates Revenue from market making, agency commission and research. The group has been building its private markets capability, and management said private M&A and growth capital mandate wins rose noticeably after investment in centralised origination.

Latest developments

For the six months to 30 September 2026, revenue fell to £22.9m from £28.5m. Investment banking revenue dropped to £17.9m from £23.5m, while equities edged up to £5.1m. Core profit before tax was £0.8m, down from £2.0m, and the statutory result was a loss before tax of £0.5m against a profit of £1.1m a year earlier. Administrative expenses fell to £23.1m from £27.6m, with employee costs down 24%, and management expects annualised savings of more than £3m over the next six months.

The group is also moving to a single chief executive. Julian Morse becomes sole CEO, while John Farrugia has stepped down as joint chief executive and left the board, although he will stay engaged on specific client work. Morse bought one million shares at 6p, taking his holding to about 2.4% of the issued share capital.

Financial picture

Cash stood at £10.6m at 30 September, down from £19.8m a year earlier, which the company attributed to earlier payment of the prior-year final Dividend and lower transaction fees. It expects cash to strengthen from December. No Interim Dividend has been declared, compared with 0.3p last year.

Sector and index context

Cavendish's fortunes are closely tied to the health of the UK small-cap market. Management pointed to the Iran conflict, disruption in the Strait of Hormuz and higher oil prices as headwinds that had weighed on UK small and mid-cap shares through Interest Rate expectations, but said it saw the recent Budget as supportive of corporate activity.

Key risks

Transaction revenue is volatile and depends on deals completing; it fell sharply in the half. A prolonged downturn would test the flexible cost base.

What to watch next

Morse cited a healthy pipeline of public and private transactions, including potential IPOs, public takeovers and Sell-Side M&A mandates, which he expects to generate greater fees over the next 12 months. Investors will look for evidence of that pipeline converting in the second half, progress on planned hires in private M&A, and any capital return once surplus cash allows.